Aclaris Therapeutics, Inc. Logo

Aclaris Therapeutics, Inc.

Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.

ACRS | US

Overview

Corporate Details

ISIN(s):
US00461U1051
LEI:
Country:
United States of America
Address:
701 LEE ROAD, 19087 WAYNE

Description

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel drug candidates for immuno-inflammatory diseases. The company leverages its core expertise in drug discovery, development, and kinase inhibition to create a pipeline of both small and large molecule drugs. Aclaris focuses on translating scientific discovery into innovative therapies to address the needs of patients with underserved conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-12 08:00
8-K
English ZIP 16.5 MB
2026-01-09 09:59 English ZIP 11.1 KB
2026-01-06 13:15
8-K
English ZIP 6.7 MB
2026-01-05 22:32 English ZIP 7.5 KB
2026-01-05 22:30 English ZIP 7.9 KB
2026-01-05 22:27 English ZIP 8.2 KB
2025-12-04 22:50 English ZIP 7.4 KB
2025-11-13 15:05 English ZIP 10.0 KB
2025-11-06 22:31
10-Q
English ZIP 1.5 MB
2025-11-06 13:01
8-K
English ZIP 111.4 KB
2025-10-14 12:59
8-K
English ZIP 27.6 MB
2025-08-07 22:31
10-Q
English ZIP 1.4 MB
2025-08-07 13:15
8-K
English ZIP 109.8 KB
2025-08-05 22:33 English ZIP 7.5 KB
2025-08-05 22:31 English ZIP 9.8 KB

Automate Your Workflow. Get a real-time feed of all Aclaris Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Aclaris Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Aclaris Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Biosergen AB Logo
Develops drugs to treat severe and resistant invasive fungal infections.
Sweden
BIOSGN
Bio Solution Co.,Ltd. Logo
Develops cell therapies, human tissue models, and bio-laboratory products.
South Korea
086820
Biosynex Logo
Designs and distributes medical diagnostic solutions, including rapid tests and devices.
France
ALBIO
BIO-TECHNE Corp Logo
Global supplier of reagents and instruments for research and clinical diagnostic markets.
United States of America
TECH
Bioten Co., Ltd Logo
Develops and manufactures natural health foods, cosmetics, and animal feed additives.
South Korea
289170
Biotest AG Logo
Develops and supplies plasma protein products and biotherapeutic drugs from human plasma.
Germany
BIO3
Biotika A.S. Logo
A biotechnology company that manufactures APIs for human and veterinary applications.
Slovakia
BSL
Bioton S.A. Logo
A global manufacturer of recombinant human insulin and diabetes care solutions.
Poland
BIO
BIOVENTIX PLC Logo
Develops and supplies sheep monoclonal antibodies for clinical diagnostic platforms.
United Kingdom
BVXP
Bioversys N Logo
Clinical-stage biopharma developing antibacterial therapies for antimicrobial resistance.
Switzerland
BIOV

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.